Oracle Corporation
—- Market cap
- $465.57B
- Debt
- —
- Cash
- −$31.29B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: ORCL stock price vs CSGP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CSGP's multiple
Needs CSGP P/E.
Implied fair value · at ORCL's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Oracle Corporation · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
COSTAR GROUP, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Microsoft Corporation
ORCL vs MSFT
Amazon.com, Inc.
ORCL vs AMZN
Alphabet Inc.
ORCL vs GOOGL
International Business Machines Corporation
ORCL vs IBM
Cisco Systems, Inc.
ORCL vs CSCO
Salesforce, Inc.
ORCL vs CRM
WELLTOWER INC.
ORCL vs WELL
Prologis, Inc.
ORCL vs PLD
Public Storage
ORCL vs PSA
EQUITY RESIDENTIAL
ORCL vs EQR
CROWN CASTLE INC.
ORCL vs CCI
CENTERSPACE
ORCL vs CSR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ORCL's current profitability and cash-generation profile deserve a premium to CSGP's earnings-distorted CSGP multiple, then maintain or accumulate ORCL because its 24.0x P/E is far more grounded in actual earnings than CSGP's 1498.0x P/E; however, if you are anchoring on the DCF range, the upside case is less compelling.
On a P/E basis, ORCL looks dramatically underpriced versus CSGP-implied figure, but that implied price is mechanically inflated by CSGP's minimal earnings base and 1498.0x P/E. The stock also trades within its historical band and inside the DCF range, which tempers the apparent upside from CSGP multiple.
Supporting Metrics